Anna Radomski

1.4k total citations
16 papers, 996 citations indexed

About

Anna Radomski is a scholar working on Cancer Research, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anna Radomski has authored 16 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 5 papers in Surgery and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anna Radomski's work include Protease and Inhibitor Mechanisms (6 papers), Platelet Disorders and Treatments (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Anna Radomski is often cited by papers focused on Protease and Inhibitor Mechanisms (6 papers), Platelet Disorders and Treatments (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Anna Radomski collaborates with scholars based in Canada, United States and Ireland. Anna Radomski's co-authors include Paul Jurasz, Marek Radomski, David Alonso‐Escolano, Tadeusz Maliñski, Maria T. Morandi, Marek W. Radomski, Grzegorz Sawicki, David M. Olson, Michael W. Stewart and Carlos Medina and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Anna Radomski

16 papers receiving 969 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Radomski Canada 14 258 178 178 174 168 16 996
David Alonso‐Escolano Spain 10 253 1.0× 278 1.6× 105 0.6× 180 1.0× 175 1.0× 10 1.1k
Marek Radomski Canada 16 310 1.2× 367 2.1× 293 1.6× 318 1.8× 183 1.1× 29 2.1k
David A. Schoenfeld United States 15 447 1.7× 327 1.8× 108 0.6× 182 1.0× 85 0.5× 38 1.4k
Dina Vara United Kingdom 18 92 0.4× 229 1.3× 64 0.4× 111 0.6× 184 1.1× 28 852
Paresh P. Kulkarni India 13 295 1.1× 162 0.9× 59 0.3× 329 1.9× 105 0.6× 29 871
Yan-Zhong Chang China 15 505 2.0× 358 2.0× 184 1.0× 453 2.6× 125 0.7× 23 1.3k
Stefan Schulte Germany 25 388 1.5× 301 1.7× 48 0.3× 149 0.9× 53 0.3× 59 2.0k
Yiqin Shi China 21 245 0.9× 350 2.0× 89 0.5× 259 1.5× 73 0.4× 66 1.4k
Margarita D. Apostolova Bulgaria 21 182 0.7× 251 1.4× 35 0.2× 150 0.9× 72 0.4× 55 1.1k
Lingwei Wang China 22 100 0.4× 372 2.1× 95 0.5× 119 0.7× 42 0.3× 65 1.8k

Countries citing papers authored by Anna Radomski

Since Specialization
Citations

This map shows the geographic impact of Anna Radomski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Radomski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Radomski more than expected).

Fields of papers citing papers by Anna Radomski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Radomski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Radomski. The network helps show where Anna Radomski may publish in the future.

Co-authorship network of co-authors of Anna Radomski

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Radomski. A scholar is included among the top collaborators of Anna Radomski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Radomski. Anna Radomski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tatla, Sandy K., et al.. (2012). Wii-habilitation as balance therapy for children with acquired brain injury. Developmental Neurorehabilitation. 17(1). 1–15. 37 indexed citations
2.
Sokal, Adam, Michał Zembala, Anna Radomski, et al.. (2009). A differential release of matrix metalloproteinases 9 and 2 during coronary artery bypass grafting and off-pump coronary artery bypass surgery. Journal of Thoracic and Cardiovascular Surgery. 137(5). 1218–1224. 11 indexed citations
3.
Li, Xue, Anna Radomski, Owen I. Corrigan, et al.. (2009). Platelet Compatibility of PLGA, Chitosan and PLGA–Chitosan Nanoparticles. Nanomedicine. 4(7). 735–746. 32 indexed citations
4.
Jones, Michael, Carlos Medina, Maria José Santos-Martínez, et al.. (2009). Isosorbide-Based Aspirin Prodrugs: Integration of Nitric Oxide Releasing Groups. Journal of Medicinal Chemistry. 52(21). 6588–6598. 24 indexed citations
5.
Alonso‐Escolano, David, Carlos Medina, Katarzyna A. Cieslik, et al.. (2006). Protein Kinase Cδ Mediates Platelet-Induced Breast Cancer Cell Invasion. Journal of Pharmacology and Experimental Therapeutics. 318(1). 373–380. 41 indexed citations
6.
Hubert, Bernard, Éric Troncy, Dominique Gauvin, et al.. (2006). Increased Alveolar and Plasma Gelatinases Activity during Postpump Syndrome: Inhibition by Inhaled Nitric Oxide. Journal of Cardiovascular Pharmacology. 48(3). 71–78. 2 indexed citations
7.
Radomski, Anna, Paul Jurasz, David Alonso‐Escolano, et al.. (2005). Nanoparticle‐induced platelet aggregation and vascular thrombosis. British Journal of Pharmacology. 146(6). 882–893. 446 indexed citations
8.
Chung, Ada W.Y., Anna Radomski, David Alonso‐Escolano, et al.. (2004). Platelet–leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases. British Journal of Pharmacology. 143(7). 845–855. 47 indexed citations
9.
Mayers, Irvin, Thomas S. Hurst, Anna Radomski, et al.. (2003). Increased matrix metalloproteinase activity after canine cardiopulmonary bypass is suppressed by a nitric oxide scavenger. Journal of Thoracic and Cardiovascular Surgery. 125(3). 661–668. 19 indexed citations
10.
Radomski, Anna, et al.. (2003). Release of matrix metalloproteinase-9 during balloon angioplasty in patients with stable angina.. International Journal of Cardiology. 92(2-3). 177–180. 14 indexed citations
11.
Medina, Carlos, Sebastián Videla, Anna Radomski, et al.. (2003). Increased activity and expression of matrix metalloproteinase-9 in a rat model of distal colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 284(1). G116–G122. 76 indexed citations
12.
Radomski, Anna, Paul Jurasz, Esmond J. Sanders, et al.. (2002). Identification, regulation and role of tissue inhibitor of metalloproteinases‐4 (TIMP‐4) in human platelets. British Journal of Pharmacology. 137(8). 1330–1338. 64 indexed citations
13.
Radomski, Anna, Michael W. Stewart, Paul Jurasz, & Marek W. Radomski. (2001). Pharmacological characteristics of solid‐phase von Willebrand factor in human platelets. British Journal of Pharmacology. 134(5). 1013–1020. 27 indexed citations
14.
Jurasz, Paul, Michael W. Stewart, Anna Radomski, et al.. (2001). Role of von Willebrand factor in tumour cell‐induced platelet aggregation: differential regulation by NO and prostacyclin. British Journal of Pharmacology. 134(5). 1104–1112. 36 indexed citations
15.
Mayers, Irvin, Tom Hurst, Lakshmi Puttagunta, et al.. (2001). Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts. Journal of Thoracic and Cardiovascular Surgery. 122(4). 746–752. 40 indexed citations
16.
Radomski, Anna, Grzegorz Sawicki, David M. Olson, & Marek Radomski. (1998). The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia‐induced lung injury in newborn rats. British Journal of Pharmacology. 125(7). 1455–1462. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Alonso‐Escolano Breakdown of academic impact, for papers by Marek Radomski Breakdown of academic impact, for papers by David A. Schoenfeld Breakdown of academic impact, for papers by Dina Vara Breakdown of academic impact, for papers by Paresh P. Kulkarni Breakdown of academic impact, for papers by Yan-Zhong Chang Breakdown of academic impact, for papers by Stefan Schulte Breakdown of academic impact, for papers by Yiqin Shi Breakdown of academic impact, for papers by Margarita D. Apostolova Breakdown of academic impact, for papers by Lingwei Wang
Rankless by CCL
2026